Fortress Biotech FBIO Cash Flow Statement (2010-2026)

NASDAQ FBIO
$2.20 +0.03 (+1.38%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Fortress Biotech Quarterly Cash Flow Statement

Periods 63 quarters
Latest Jun 2026

Fortress Biotech cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 63 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-24.39M-45.86M-68.51M-49.48M-53.93M-53.06M-57.45M-55.15M-59.30M-10.72M-28.98M-39.02M-28.82M-26.69M-26.32M-24.69M-11.65M8.83M-5.40M0.60M
Depreciation and DepletionDep. & Depletion
0.60M0.70M0.73M0.74M0.80M0.80M0.81M0.84M0.80M0.40M0.33M0.40M0.40M0.10M0.14M0.13M0.10M0.10M0.09M0.10M
Share-based CompensationStock Comp.
4.35M4.33M7.04M5.56M5.08M6.84M5.51M4.73M4.22M4.38M3.70M4.86M5.00M6.57M16.19M6.29M16.79M3.20M2.46M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
-0.02M1.35M0.12M
Asset Writedowns and ImpairmentWritedown
3.14M-3.14M5.79M1.04M
Cash from OperationsCash from Ops.
-34.46M-21.70M-38.70M-46.86M-41.42M-43.27M-47.84M-43.22M-33.29M-16.78M-34.94M-25.39M-21.84M-20.06M-12.91M-19.56M-27.56M-6.11M-12.54M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.74M0.66M0.49M1.02M1.02M1.02M1.23M1.07M1.07M0.81M0.85M0.81M0.81M0.81M0.98M1.06M1.06M1.06M1.11M0.97M
Depreciation & Amortization (CF)Dep. & Amort.
0.60M0.70M0.73M0.74M0.80M0.80M0.81M0.84M0.80M0.40M0.33M0.40M0.40M0.10M0.14M0.13M0.10M0.10M0.09M0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
2.05M5.54M-8.51M8.00M-2.48M-0.08M-0.05M-0.47M-10.43M-8.83M7.18M-5.42M0.81M0.88M-0.75M7.99M-2.82M2.42M11.76M
Change in InventoryChange Inventory
12.02M-2.70M-1.75M0.23M-0.08M-0.82M-1.07M-0.88M-1.11M-1.14M-0.82M0.37M-0.89M2.10M2.64M-1.94M0.36M-1.03M-2.19M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
8.29M28.12M9.35M2.19M2.01M0.21M3.94M4.77M-4.34M-17.45M-7.36M2.67M-4.80M-4.99M0.73M0.55M-8.37M-2.83M2.68M
Change in TaxesChange Taxes
0.34M0.00M-0.00M0.01M0.36M0.00M0.08M0.04M-0.04M0.04M0.08M0.02M0.03M0.02M-0.65M
Other Working Capital ChangesOther WC Changes
-2.40M-1.45M-0.74M-1.34M-0.60M0.43M4.11M-1.20M-1.04M-0.97M4.07M1.57M-3.41M-2.07M2.94M-2.38M0.02M-1.74M2.55M
Investing Activities
Capital ExpendituresCapex
1.69M0.46M1.96M1.34M0.31M0.98M0.09M0.03M0.00M0.03M-1.40M
Sales of Property, Plant and EquipmentPP&E (Sale)
1.17M
Change in IntangiblesChange Intangibless
2.75M7.08M1.55M-19.66M3.00M15.00M
Acquisitions
-20.00M-5.00M
Divestments
2.87M
Cash from Investing ActivitiesCash from Investing
-4.84M-7.54M53.35M-21.34M-0.31M-0.89M-0.39M-5.00M-2.04M5.00M-0.06M-15.00M1.17M6.09M2.87M
Financing Activities
Other financing activitiesOther financing
0.00M0.04M
Cash from Financing ActivitiesCash from Financing
24.39M6.97M38.94M49.96M2.99M3.75M18.62M22.19M-30.38M-2.69M43.62M27.86M14.27M2.71M25.81M52.14M4.52M15.07M5.71M
Debt Issuance and Repayment
Non-Current Debt
5.00M-0.00M14.62M-0.05M5.00M
Change in Capital Stock
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.14M2.61M6.34M4.23M1.30M0.22M0.30M0.45M0.72M0.89M-0.01M0.89M1.93M0.57M0.34M1.01M-0.00M1.27M0.37M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.18M0.18M0.18M0.18M0.18M0.18M0.17M0.17M0.17M0.17M0.17M
Dividends Paid - PreferredDiv. Paid (Pref.)
2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M
Dividends Paid - Common and PrefferdDiv Paid (Total)
0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.18M0.18M0.18M0.18M0.18M0.18M0.17M0.17M0.17M0.17M0.17M
Additional items
Change in Cash
-14.90M-22.27M53.60M-18.23M-38.74M-40.42M-29.62M-26.03M-65.71M-14.46M8.62M2.47M-7.57M-17.35M-2.10M33.74M-16.95M11.83M-6.84M
Free Cash FlowFCF
-36.15M-22.16M-40.65M-48.20M-41.73M-44.25M-47.94M-43.22M-33.33M-16.78M-34.96M-25.39M-21.84M-18.66M-12.91M-19.56M-27.56M-6.11M-12.54M
Net Cash FlowNCF
-14.90M-22.27M53.60M-18.23M-38.74M-40.42M-29.62M-26.03M-65.71M-14.46M8.62M2.47M-7.57M-17.35M-2.10M33.74M-16.95M11.83M-6.84M

Fortress Biotech Cash Flow Statement API

Pull Fortress Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY